Veracyte

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Veracyte and other ETFs, options, and stocks.

About VCYT

Veracyte, Inc. engages in the research, development and commercialization of diagnostic products. The firm's portfolio includes Afirma, Percepta, and Envisia. 

CEO
Marc A. Stapley
CEOMarc A. Stapley
Employees
755
Employees755
Headquarters
South San Francisco, California
HeadquartersSouth San Francisco, California
Founded
2006
Founded2006
Employees
755
Employees755

VCYT Key Statistics

Market cap
3.90B
Market cap3.90B
Price-Earnings ratio
44.82
Price-Earnings ratio44.82
Dividend yield
Dividend yield
Average volume
1.27M
Average volume1.27M
High today
$50.54
High today$50.54
Low today
$48.80
Low today$48.80
Open price
$49.16
Open price$49.16
Volume
698.42K
Volume698.42K
52 Week high
$50.71
52 Week high$50.71
52 Week low
$22.61
52 Week low$22.61

Stock Snapshot

Veracyte(VCYT) stock is priced at $48.88, giving the company a market capitalization of 3.9B. It carries a P/E multiple of 44.82.

On 2026-06-04, Veracyte(VCYT) stock moved within a range of $48.80 to $50.54. With shares now at $48.88, the stock is trading +0.2% above its intraday low and -3.3% below the session's peak.

Trading volume for Veracyte(VCYT) stock has reached 698.42K, versus its average volume of 1.27M.

Over the past 52 weeks, Veracyte(VCYT) stock has traded between a high of $50.71 and a low of $22.61.

Over the past 52 weeks, Veracyte(VCYT) stock has traded between a high of $50.71 and a low of $22.61.

VCYT News

TipRanks 3d
Veracyte assumed with an Outperform at Wolfe Research

Wolfe Research assumed coverage of Veracyte (VCYT) with an Outperform rating and price target of $55, up from $50. The company’s testing assets, Afirma and Deci...

Simply Wall St 3d
Assessing Veracyte Valuation After A Strong 40% Monthly Share Price Gain

Advertisement Recent share performance and business overview Veracyte (VCYT) stock has caught investor attention after a strong month and past 3 months, with...

Assessing Veracyte Valuation After A Strong 40% Monthly Share Price Gain

Analyst ratings

82%

of 11 ratings
Buy
81.8%
Hold
9.1%
Sell
9.1%

People also own

Based on the portfolios of people who own VCYT. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.